EU APPROVES NEW PHARMACOVIGILANCE RULES
October 1st, 2012 BY KEITH NUTHALL THE EUROPEAN Union (EU) Council of Ministers and the European Parliament have agreed reforms to EU pharmacovigilance legislation. Under the revisions, if a company decides not to renew a marketing licence over safety reasons, an emergency evaluation at the EU level would be staged. Also, when companies voluntarily withdraw a drug, they must declare if it is because of safety. And all drugs subject to post-authorisation safety studies will be labelled as such, to make patients aware. The new rules will come into force by the end of 2013. They ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.